Will Martin Shkreli's Twitter Boot Impact His Upcoming Securities Fraud Trial?
A Twitter suspension could find its way into the hands of the prosecution, here's how...
Takeda Pharmaceutical to buy Ariad in $4.7 billion cash deal
Japanese drugmaker Takeda Pharmaceutical has agreed to buy U.S. cancer drug developer Ariad Pharmaceuticals in a $4.7 billion deal.
Home Test a New Easy Way to Screen for Colon Cancer
One of the deadliest cancers in the United States can now be detected in the privacy of your own home.
Is Hillary Clinton Above the Law?
During an interview with the FOX Business Network’s Maria Bartiromo, California Republican lawmaker Darryl Issa provided detailed analysis of Hillary Clinton’s email probe.
Ex-HHS Secretary Kathleen Sebelius: Obamacare Repeal Will Cause 'Pure Chaos'
A repeal of Obamacare would set off mass confusion and chaos, Kathleen Sebelius , the Secretary of Health and Human Services under President Obama, said Wednesday.
Allergan CEO Promises to Keep Drug Prices Affordable
Allergan CEO Brent Saunders says drug price increases have to stop. During an interview with the FOX Business Network’s Maria Bartiromo he discussed Allergan’s “social contract with patients” to cap drug prices.
Martin Shkreli's Lawyer Brafman Sheds Light on Price Gouging
Ben Brafman told FOX Business he's 'represented personalities a lot more difficult' than former drug CEO Martin Shkreli.
Trump: You Have to Get Hit By a Komatsu Tractor to Use Obamacare
In a wide-ranging interview with FOX Business Network’s Maria Bartiromo, GOP Presidential Candidate Donald Trump said he will be releasing a comprehensive tax reform plan over the next four weeks that would cut taxes.
Omega’s Cooperman: Bargains Gone, But Stocks Still Place to Be
With a record run in the stock market, deals might be few and far between, but Omega Advisors CEO Leon Cooperman said stocks are still the place to be.
Merck CEO: Major Breakthrough in Lung Cancer Treatment
During an interview with the FOX Business Network’s Maria Bartiromo Merck CEO Kenneth Frazier said the company has found, based on new data released over the weekend, how its immune therapy drug Keytruda may help to fight advanced lung cancer.
Turing CEO Martin Shkreli Unapologetic for 5,000% Drug Price Hike
The price-gouging pharmaceutical CEO under fire for increasing the price of HIV/AIDS drug, Daraprim from $18 to $750 per pill is unapologetic. During an interview with the FOX Business Network’s Maria Bartiromo, Turing CEO Martin Shkreli explained what was behind the move.
Eli Lilly CEO: Our Drug Prices are Fair
Eli Lilly CEO John Lechleiter thinks the presidential election will drum up more controversy over drug prices. During an interview on FOX Business Network’s Mornings with Maria he said: “If you look back on at least a four-year cycle we see a lot more noise around pricing as we approach the presidential election.”
Nurses Plan To 'Fight Like Hell' for Single-Payer Health Care
Nurses are fighting for Bernie Sanders and single-payer health care.
Nurses Plan To 'Fight Like Hell' for Single-Payer Health Care
Nurses are fighting for Bernie Sanders and single-payer health care.
Cleveland Clinic CEO Has a Warning for All U.S. Hospitals
Fixing America’s health care system is more than addressing rising costs according to Dr. Toby Cosgrove, CEO of the Cleveland Clinic, one of the most technically advanced medical facilities in the country.
J&J's Baby Powder Problem a Blow to Its Bottom Line?
Johnson & Johnson will pay a woman $55 million after claims that its talcum powder caused her to develop ovarian cancer.
Lilly’s New Diabetes Drug Delivers “One of a Kind” Results
In an interview with FOX Business Network’s Maria Bartiromo, Lilly Diabetes President Enrique Conterno discussed the company’s new drug for patients with type-2 diabetes.
Novartis, Google Creating Lenses that Correct Vision in a Millisecond
Novartis is turning to innovation for growth. That’s why the company has decided to partner with Google to develop high tech contact lenses to correct vision and perhaps help diabetics.
Aetna, Humana CEOs Say Industry Consolidation Good for Consumer
After weeks of intense discussions on possible mergers among the five biggest U.S. health insurers, Aetna announced it would buy Humana in a deal valued at $37 billion -- the largest insurance industry deal to date.
Johnson and Johnson CEO: Cancer Research Is Paying Off
Johnson and Johnson has 10 new products in the pharmaceutical pipeline that could potentially earn the company $10 billion in revenue, according to CEO Alec Gorsky.

















